Basma Adeem Medical company (TADAWUL:9626)
Saudi Arabia flag Saudi Arabia · Delayed Price · Currency is SAR
5.03
-0.01 (-0.20%)
Oct 8, 2025, 2:44 PM AST

TADAWUL:9626 Income Statement

Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22
37.2933.9226.5221.92
Revenue Growth (YoY)
70.12%27.88%20.99%-
Cost of Revenue
25.7222.9818.1915.02
Gross Profit
11.5810.948.336.9
Selling, General & Admin
3.633.142.482.57
Operating Expenses
3.913.412.742.69
Operating Income
7.677.525.594.21
Interest Expense
-0.56-0.34-0.36-0.29
Interest & Investment Income
0.10.1--
Other Non Operating Income (Expenses)
-0.24-0.5-0.3-
EBT Excluding Unusual Items
6.976.784.933.92
Other Unusual Items
-0-00.13-
Pretax Income
6.966.785.063.92
Income Tax Expense
0.490.480.190.14
Net Income
6.476.34.873.78
Net Income to Common
6.476.34.873.78
Net Income Growth
71.11%29.40%28.71%-
Shares Outstanding (Basic)
171210-
Shares Outstanding (Diluted)
171210-
Shares Change (YoY)
-21.59%--
EPS (Basic)
0.380.550.51-
EPS (Diluted)
0.380.550.51-
EPS Growth
-6.42%--
Free Cash Flow
3.826.664.075.24
Free Cash Flow Per Share
0.230.580.43-
Gross Margin
31.05%32.25%31.41%31.46%
Operating Margin
20.57%22.18%21.07%19.20%
Profit Margin
17.36%18.58%18.36%17.26%
Free Cash Flow Margin
10.24%19.64%15.34%23.90%
EBITDA
8.338.156.24.54
EBITDA Margin
22.33%24.02%23.36%20.71%
D&A For EBITDA
0.660.620.610.33
EBIT
7.677.525.594.21
EBIT Margin
20.57%22.18%21.07%19.20%
Effective Tax Rate
7.04%7.11%3.69%3.56%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.